These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19405791)

  • 1. Treatment of acute bacterial exacerbations of chronic bronchitis.
    Siempos II; Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2009 May; 10(7):1173-82. PubMed ID: 19405791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
    Dever LL; Shashikumar K; Johanson WG
    Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
    Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
    Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbations of chronic bronchitis: an international comparison.
    Ball P; Make B
    Chest; 1998 Mar; 113(3 Suppl):199S-204S. PubMed ID: 9515893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy of exacerbations of chronic bronchitis.
    Niederman MS
    Semin Respir Infect; 2000 Mar; 15(1):59-70. PubMed ID: 10749551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious exacerbations of chronic bronchitis: diagnosis and management.
    Sethi S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():97-105. PubMed ID: 10225579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
    Niederman MS
    Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy.
    Saint S; Flaherty KR; Abrahamse P; Martinez FJ; Fendrick AM
    Clin Ther; 2001 Mar; 23(3):499-512. PubMed ID: 11318083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis.
    Peng CC; Aspinall SL; Good CB; Atwood CW; Chang CC
    South Med J; 2003 Oct; 96(10):986-91. PubMed ID: 14570342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials.
    Dimopoulos G; Siempos II; Korbila IP; Manta KG; Falagas ME
    Chest; 2007 Aug; 132(2):447-55. PubMed ID: 17573508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antimicrobial therapy in acute exacerbations of chronic bronchitis.
    Campbell GD
    Am J Med Sci; 1999 Aug; 318(2):84-8. PubMed ID: 10452565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
    Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
    Siempos II; Dimopoulos G; Korbila IP; Manta K; Falagas ME
    Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.
    Schaberg T; Möller M; File T; Stauch K; Landen H
    Clin Drug Investig; 2006; 26(12):733-44. PubMed ID: 17274680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
    Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.
    Lorenz J; Thate-Waschke IM; Mast O; Kubin R; Rychlik R; Pfeil T; Daniel D; Tillotson GS
    J Int Med Res; 2001; 29(2):74-86. PubMed ID: 11393351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute exacerbations of chronic obstructive pulmonary disease.
    Adkison JD; Konzem SL
    Pharmacotherapy; 2001 Aug; 21(8):929-39. PubMed ID: 11718499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials.
    Madaras-Kelly KJ; Magdanz SB; Johnson CK; Jue SG
    Ann Pharmacother; 2002 Jun; 36(6):975-80. PubMed ID: 12022895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
    Torrance G; Walker V; Grossman R; Mukherjee J; Vaughan D; La Forge J; Lampron N
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):499-520. PubMed ID: 10662396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.